Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

09:24 EDT 22nd July 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 8,000+

Friday 18th July 2014

Breakthrough Discovery Provides New Hope for Cancer Patients Fighting Infection

NFCR supported scientist Laurence Cooper, M.D., Ph.D., and his team at the MD Anderson Cancer Center have engineered a novel treatment for killing fungal infections that are often lethal to cancer patients with weakened immune systems. Bethesda, MD (PRWEB) July 18, 2014 NFCR supported scientist Laurence Cooper, M.D., Ph.D., and his team at the MD Anderson Cancer Center have engineered a novel tre...

Gene links stem cells, aging and cancer

An organism is healthy thanks to a good maintenance system: […]

It’s complicated: Analyzing the costs, benefits of gene-modifying technology

What if we had the technology to eradicate malaria and […]

Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval

BUFFALO, N.Y., July 18, 2014 /PRNewswire-USNewswire/ -- The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute (RPCI) approval to begin genomic testing of cancer patients using its OmniSeq TargetTM advanced molecular diagnostic laboratory test. The test, approved through the DOH's Clinical Laboratory Evaluation Program (CLEP), is part of a comprehensive appro...

aTyr Pharma Inc., The Scripps Research Institute And Stanford University Join In The Discovery Of A New Class Of Human Proteins

Could CRISPR Transform Wild Ecosystems?

Bio-IT World | In a paper published yesterday in the open access journal eLife, George Church and colleagues discuss the potential for "gene drives" that alter the genomes of whole wild populations using CRISPR gene editing technology, and weigh the...

WaferGen Bio-Systems Announces Appointment of Ivan Trifunovich as Chairman of the Board; Joel Kanter to Serve as Lead Independent Director

FREMONT, Calif., July 18, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBSD) today announced that its Board of Directors has appointed Ivan Trifunovich, the company's President and Chief Executive Officer, as Chairman of the Board.  Joel Kanter, a director of the company since 2007, will serve as lead independent director.  Alnoor Shivji, the company's Chairman since 200...

Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Followi...

Charlotte, NC Assisted Living Community The Crossings At Steele Creek Welcomes First Residents

Saber Healthcare Opens Doors For Seniors Seeking Life Fulfilling Care Charlotte, NC (PRWEB) July 18, 2014 The professional staff at The Crossings at Steele Creek welcomed the first residents this week. The new, upscale community recently opened to serve an increasing demand for fresh, upscale assisted living in Charlotte, one of the fastest growing U.S. cities. Saber Healthcare Group, a leader in...

Acyclovir Almost Ineffective Against Herpes Outbreaks; polyDNA Reviews the Medical Evidence

Acyclovir modestly improved healing time and duration of pain by as much as half a day, according to the Journal of Family Practice in a study published in February, 2014. (1) polyDNA recommends two natural HSV remedies against the latent HSV. Rochester, NY (PRWEB) July 18, 2014 “Infected with the herpes virus? We recommend taking Novirin or Gene-Eden-VIR.” – Greg Bennett, CBCD Most people...

New Mesothelioma Research Website Offers In-Depth Articles About Technology and Treatment

ResearchMesotheliomaCancer.com is sure to be an outstanding resource for Mesothelioma patients and their families. Los Angeles, CA (PRWEB) July 18, 2014 ResearchMesotheliomaCancer.com, a website that is devoted to helping mesothelioma patients and their families learn all they can about the serious form of cancer, has just launched its new and user-friendly website. In addition to explaining abou...

Regulation of developmental gene expression occurs in the reverse order to that expected

Molecular modification of DNA and the histone proteins it is bound to is one of the key mechanisms responsible for regulating gene expression. Polycomb-group proteins play an important role in some of these modification processes, but the molecular m...

Researchers uncover new cancer cell vulnerability

(Medical Xpress)—Yale School of Medicine and Yale Cancer Center researchers have uncovered a genetic vulnerability of cancer cells that express telomerase—an enzyme that drives their unchecked growth—and showed that telomerase-expressing cells...

Genetic Blueprint of Bread Wheat Genome Unveiled

BETHESDA, Md., July 18, 2014 /PRNewswire/ -- The International Wheat Genome Sequencing Consortium (IWGSC) published today in the international journal Science a draft sequence of the bread wheat genome. The chromosome-based draft provides new insight into the structure, organization, and evolution of the large, complex genome of the world's most widely grown cereal crop. The genetic blueprint is...

Political scientist discusses regulatory gaps in assessing the impact of "gene drives"

Imagine a scientific technique that would alter the genes of mosquitos to render them unable to transmit malaria. Some day, you may not need to: Scientists have made notable progress in recent years in editing the genomes of organisms, substituting i...

Doctor maps path of discovery for developing potential anticancer agent

The journal Cancer Cell today published research led by Dr. Tak Mak mapping the path of discovery to developing a potential anticancer agent.

Ensemble Discovery Corporation - Product Pipeline Review - 2014

Ensemble Discovery Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Ensemble Discovery Corporation - Product Pipeline Review - 2014’, provides an overview of the Ensemble Discovery Corporation’s pharmaceutical researc...

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 37-page report is available in PDF from $2000. Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acid Sphing...

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 63-page report is available in PDF from $2000. Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Hyperc...

Batten Disease - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Batten Disease - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 39-page report is available in PDF from $2000. Batten Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2014’, provides an overview of the Batten Disease’s therapeutic pi...

Respiratory Depression - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Respiratory Depression - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 45-page report is available in PDF from $2000. Respiratory Depression - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Respiratory Depression - Pipeline Review, H2 2014’, provides an overview of the Respirato...

Malignant Mesothelioma - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Malignant Mesothelioma - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 100-page report is available in PDF from $2000. Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignan...

Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 114-page report is available in PDF from $2000. Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014’, provides an ove...

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-14. This 126-page report is available in PDF from $2000. Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ...

MYOS enters into R&D agreement with Cloud Pharmaceuticals

MYOS, an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, has entered into a research and development agreement with Cloud Pharmaceut...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement